Escolar Documentos
Profissional Documentos
Cultura Documentos
Untuk nomor 41 51
Although great efforts have been exerted by the World Health Organization (WHO)
to reduce the public health burden of measles, the disease remains the leading
cause of vaccine-preventable child morbidity and mortality worldwide, particularly
in developing countries where immunization coverage is low and vitamin A
deficiency is common. Globally, more than 20 million measles cases are reported
annually with 345.000 deaths in 2005, which represent 50 60% of the estimated
1.6 million deaths attributed to vaccine-preventable diseases of childhood. Failure to
deliver at least one dose of measles vaccine to all infants remains the main reason
for high measles morbidity and mortality as 95% coverage is required to interrupt
measles transmission. In Indonesia, measles remain an important cause of
morbidity and mortality in children under five years of age. Measles outbreaks,
confirmed by IgM antibody diagnosis, have been recently reported in many parts of
the country. In late 2002 and early 2003, measles epidemic were reported from at
least six provinces of Java and in the first three months of 2003 more than 150
patients with measles were admitted to the pediatric wards of Government Hospital
in Java Island. In order to determine the factors associated with the disease
outbreak and provide information for future disease prevention planning, we
conducted a retrospective case-control study comparing potential risk factors
between children with and without measles who were admitted at Government
Hospital in Java Island.
41. Describe the persons with vaccine-preventable diseases (cases) who were
identified by your surveillance system. Attributes of the case-patients include age
group, sex, and race or ethnicity. It may be appropriate to divide age groups based
on recommended ages for vaccine administration as well as on the age distribution
of persons with reported cases. Please interpret the data below:
Age group
Frequency
%
Cumulative (%)
< 6 month
57
36.1
36.1
6 12 month
41
25.9
62.0
13 18 month
6
3.8
65.8
19 23 month
6
3.8
69.6
2 5 year
18
11.4
81.0
6 9 year
17
10.8
91.8
10 year
12
7.6
99.4
Age unknown
1
0.6
100
Total
158
100
A. measles cases are clustered among infants, with more than 25% of reported
cases among those 12 months of age and younger
B. measles cases are clustered among infants, with more than 60% of reported
cases among those 12 months of age and younger
C. measles cases are clustered among infants, with more than 11% of reported
cases among those 5 years old and younger
D. measles cases are clustered among infants, with more than 80% of reported
cases among those 5 years old and younger
E. measles cases are clustered among infants, with more than 99% of reported
cases among those 10 years old and younger
42. based on disease incidence, this condition might be have a risk to get high
mortality rate, because:
A. The distribution of disease transmission was very high
B. The route of transmission difficult to draw any conclusion
C. The age group can explained how big the effect of disease prevention
D. The occurrence of pertussis among infants younger than 6 months of age is
extremely high
E. The presentation of data in such unequal age groups may obscure important
differences in disease incidence.
43. if you want to test some medical treatment to controlling transmission of
measles outbreak, which one of the following statement that recommended be
expected o increase the statistical power of a clinical trial to test a new medical
treatment?
A. Treating a more clinically heterogenous group of patients
B. Narrowing the trial to allow enrollment of more patients
C. adopting new measures to ensure compliance with therapy
D. Adopting a more stringent standard of evidence to prove the new treatment
works
E. Testing only a subgroup of patients for whom the new drug would be expected to
have the greates advantage
60
50
40
30
Number of Reported Cases
20
10
0
Age Group
350
300
250
200
150
Incidence per 100.000 population
100
50
0
Age Group
Untuk nomor 46 47
Sex
Female
Male
Total
Frequency
27
12
39
%
69.3
30.7
100
Cumulative %
69.3
100
Frequency
32
77
49
158
%
20.35
48.7
31.0
100
Cumulative %
20.3
69.0
100
51. If there are any indicating disproportionate burden of disease in one group from
previous reports, that might be caused by:
A. Different levels of reporting
B. High rates of vaccine coverage
C. High reporting practices among providers
D. Appropriate system in access to medical care
E. Decease disease incidence in certain neighborhoods or communities
53. Surveillance data which is analyzed and disseminated on a regular and ongoing
basis helps us know when and how to take public health action. In which condition
surveillance data important to detect and control outbreak of disease?
A. Monitoring changes in health practices and behaviors
B. Monitoring persons within the population at high risk for complications
C. Determine the etiology and natural epidemiological history of diseases,
environmental
D. Detection occupational exposures, and health behaviors, and increases and
decreases in their occurrence over time.
E. Data collection concerning influenza activity every years is disseminated to
health care providers and used to determine when intensified vaccination efforts.
54. In which condition data collection activity useful for monitoring changes in
health practices and behaviors?
A. information concerning life-style habits
B. Information about new drug from drug store
C. Information about new exposures of the disease
D. Information about persons within the population at high risk for complications
E. Information about new etiology and natural epidemiological history of diseases
55. In which condition surveillance data also helps us evaluate the effectiveness
treatment programs at reaching at-risk populations?
A. Increase prevention programs at hospital
B. Develop new policy about regulation of vaccine at school
C. Informs individuals about good habits due to health condition
D. Adoption of policy about management of infectious disease at hospital
E. Make new organizations that responsible for the development new policy
56. Analyses of surveillance data should take place on a regular and ongoing basis
with special analyses added when disease outbreaks or unusual health conditions
occurs. Results from data analyses should be:
A. Reviewed regularly
B. Report after outbreak cases appear
C. Reported to Ministry of Health officer
D. Reviewed originally by Ministry of Health
E. Reported back to local government officer
Maaf pada ga ngumpulin >.< Yang bagian saya juga lupa, maaf
Back Up
1. What is the level of significant?
a. Probability of rejecting Ho when Ho is true
b. Probability of rejecting Ho when Ho is false
c. Probability of accepting Ho when Ho is true
d. Probability of accepting Ho when Ho is false
e. Probability of rejecting Ho when H1 is true
Sisanya ga ada, puntenn
Titipan
For the question number 79-80, refer to the scenario below
A common symptom of otitis media in young children is the prolonged presence of
fluid in the middle ear, as known as middle-ear effusion. The presence of fluid may
result in temporary hearing loss and interfere with normal hearing skills in the first
two years of life. One hypothesis is that babies who are breast-fed for at least 1
month build up some immunity against the effects of the disease and have less
prolonged effusion than do bottle-fed babies. A snakk study of 34 pairs of babies is
set up, where the babies are matched on a one to one basis, according to age, sex,
socioeconomic status, and type of medication taken. One member of the matched
pair is a breast-fed baby and the other is a bottle-fed baby. The outcome variable is
the duration of middle-ear effusion after the first episode of otitis media.
79.What hypotheses are being tested here?
a. Ho : duration of middle-ear effusion in breastfed baby = duration of middleear effusion in bottlefed baby. H1 : duration of middle-ear effusion in
breastfed baby duration of middle-ear effusion in bottlefed baby
b. Ho : duration of middle-ear effusion in breastfed baby duration of otitis
media in bottlefed baby. H1 : duration of middle-ear effusion in breastfed
baby > duration of middle-ear effusion in bottlefed baby
c. Ho : duration of middle-ear effusion in breastfed baby = duration of middleear effusion in bottlefed baby. H1 : duration of middle-ear effusion in
breastfed baby < duration of middle-ear effusion in bottlefed baby
d. Ho : duration of middle-ear effusion in breastfed baby duration of middleear effusion in bottlefed baby. H1 : duration of middle-ear effusion in
breastfed baby < duration of middle-ear effusion in bottlefed baby
e. Ho : duration of middle-ear effusion in breastfed baby = duration of middleear effusion in bottlefed baby. H1 : duration of middle-ear effusion in
breastfed baby > duration of middle-ear effusion in bottlefed baby
80.Which non-parametric test should be use here?
a. Friedman
b. Chi-square
c. Kruskal-wallis
d. Mann-whitney-U
e. Wilcoxon-signed-rank
For questions number 81-82, refer to the scenario below:
A pilot study is planned to test the efficacy of vitamin E supplementation as a
possible preventive agent for Alzheimers disease. Twenty subjects age 65+ are
randomized to either a supplement of vitamin E 400 UI/day (group 1, n=20), or
placebo (group 2, n = 20). It is important to establish that the vitamin E intake (from
food and supplements) of the two groups is comparable at baseline.
81.What hypotheses are being tested here?
a. Ho : total vitamin E intake in group 1 = total vitamin E intake in group
H1 : total vitamin E intake in group 1 total vitamin E intake in group 2
b. Ho : total vitamin E intake in group 1 total vitamin E intake in group
H1 : total vitamin E intake in group 1 > total vitamin E intake in group 2
c. Ho : total vitamin E intake in group 1 total vitamin E intake in group
H1 : total vitamin E intake in group 1 < total vitamin E intake in group 2
d. Ho : total vitamin E intake in group 1 = total vitamin E intake in group
H1 : total vitamin E intake in group 1 > total vitamin E intake in group 2
e. Ho : total vitamin E intake in group 1 = total vitamin E intake in group
H1 : total vitamin E intake in group 1 < total vitamin E intake in group 2
82.Which non-parametric test should be use here?
a. Friedman
2.
2.
2.
2.
2.
b.
c.
d.
e.
Chi-square
Kruskal-Wallis
Mann-Whitney-U
Wilcoxon-signed-rank
d. Mann-Whitney-U
e. Wilcoxon-signed-rank
86.One medical student wants to test a hypothesis that birthweight of an infant is
associated with smoking status of the mother during first semester of pregnancy.
She records birthweights of infants (grams) and smoking status of the mother
and divides the smoking status into four groups: non-smoker, ex-smoker, current
smoker and smokes less than 1 pack per day, and current smoker and smokes 1
pack per day or more. If assumptions for parametric test are not met, which of
the following is the CORRECT alternative test?
a. Friedman
b. Kruskal-Wallis
c. Wilcoxon-sum-rank
d. Wilcoxon-signed-rank
e. Kolgomorov Smirnov